539 related articles for article (PubMed ID: 11503313)
1. [Limited role of naltrexone in the treatment of opiate addiction].
van Brussel GH
Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1452-6. PubMed ID: 11503313
[TBL] [Abstract][Full Text] [Related]
2. [Detoxication in opiate addiction and prevention of recurrence: administration of naltrexone and cognitive behavior therapy].
Roozen HG; Deden AL; Kerkhof AJ; Vorsteveld JP; van den Brink W
Ned Tijdschr Geneeskd; 1997 Dec; 141(49):2377-80. PubMed ID: 9554156
[TBL] [Abstract][Full Text] [Related]
3. [Long-acting naltrexone--a new way out of opiate addiction?].
Stavseth LS; Kunøe N; Tanum L
Tidsskr Nor Laegeforen; 2013 Nov; 133(21):2231-2. PubMed ID: 24226324
[No Abstract] [Full Text] [Related]
4. Favorable mortality profile of naltrexone implants for opiate addiction.
Reece AS
J Addict Dis; 2010 Jan; 29(1):30-50. PubMed ID: 20390697
[TBL] [Abstract][Full Text] [Related]
5. Vivitrex (Alkermes/Cephalon).
Heading CE
Curr Opin Investig Drugs; 2006 Jan; 7(1):81-8. PubMed ID: 16425675
[TBL] [Abstract][Full Text] [Related]
6. Ultra-rapid opiate detoxification followed by nine months of naltrexone maintenance therapy in Iran.
Naderi-Heiden A; Naderi A; Naderi MM; Rahmani-Didar F; Salimi AR; Gleiss A; Kasper S; Frey R
Pharmacopsychiatry; 2010 Jun; 43(4):130-7. PubMed ID: 20101570
[TBL] [Abstract][Full Text] [Related]
7. [Opioid detoxication under general anesthesia].
Zemtsovski MJ; Trosko O; Schmidt H
Ugeskr Laeger; 2002 Sep; 164(36):4165-9. PubMed ID: 12362827
[TBL] [Abstract][Full Text] [Related]
8. Comparative treatment and mortality correlates and adverse event profile of implant naltrexone and sublingual buprenorphine.
Reece AS
J Subst Abuse Treat; 2009 Oct; 37(3):256-65. PubMed ID: 19394789
[TBL] [Abstract][Full Text] [Related]
9. [Naltrexone in the treatment of addiction].
Bachs L; Waal H
Tidsskr Nor Laegeforen; 2003 Jun; 123(12):1665-7. PubMed ID: 12821984
[TBL] [Abstract][Full Text] [Related]
10. What you need to know: addiction--prescribing naltrexone.
Yeo BK
Singapore Med J; 1997 Feb; 38(2):92-3. PubMed ID: 9269372
[TBL] [Abstract][Full Text] [Related]
11. Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels.
Foster J; Brewer C; Steele T
Addict Biol; 2003 Jun; 8(2):211-7. PubMed ID: 12850780
[TBL] [Abstract][Full Text] [Related]
12. The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction.
Simon DL
Conn Med; 1996 Nov; 60(11):683-5. PubMed ID: 8979434
[No Abstract] [Full Text] [Related]
13. Narcotic antagonists in drug dependence: pilot study showing enhancement of compliance with SYN-10, amino-acid precursors and enkephalinase inhibition therapy.
Chen TJ; Blum K; Payte JT; Schoolfield J; Hopper D; Stanford M; Braverman ER
Med Hypotheses; 2004; 63(3):538-48. PubMed ID: 15288384
[TBL] [Abstract][Full Text] [Related]
14. Outcome and six month follow up of patients after Ultra Rapid Opiate Detoxification (UROD).
Albanese AP; Gevirtz C; Oppenheim B; Field JM; Abels I; Eustace JC
J Addict Dis; 2000; 19(2):11-28. PubMed ID: 10809517
[TBL] [Abstract][Full Text] [Related]
15. Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy.
Degenhardt L; Gibson A; Mattick RP; Hall W
Drug Alcohol Rev; 2008 Jan; 27(1):1-3. PubMed ID: 18034375
[No Abstract] [Full Text] [Related]
16. Clinical treatment of opioid addiction and dependence.
Ling W; Rawson RA; Compton M
Methods Mol Med; 2003; 84():285-95. PubMed ID: 12703332
[No Abstract] [Full Text] [Related]
17. Review of naltrexone, a long-acting opiate antagonist.
Crabtree BL
Clin Pharm; 1984; 3(3):273-80. PubMed ID: 6329589
[TBL] [Abstract][Full Text] [Related]
18. Long-term relapse of ultra-rapid opioid detoxification.
Salimi A; Safari F; Mohajerani SA; Hashemian M; Kolahi AA; Mottaghi K
J Addict Dis; 2014; 33(1):33-40. PubMed ID: 24471478
[TBL] [Abstract][Full Text] [Related]
19. Antagonist treatment of opioid withdrawal translational low dose approach.
Mannelli P; Gottheil E; Van Bockstaele EJ
J Addict Dis; 2006; 25(2):1-8. PubMed ID: 16785213
[TBL] [Abstract][Full Text] [Related]
20. The sequential use of clonidine and naltrexone in the treatment of opiate addicts.
Gold MS; Dackis CA; Washton AM
Adv Alcohol Subst Abuse; 1984; 3(3):19-39. PubMed ID: 6388273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
